Recent in North America (page 15 of 17)

Border Inspection Slows

The number of Food and Drug Administration(FDA) border inspectors has seen a drastic drop in the past four years.

Cleaner Products for CARB

The California Air Resources Board (CARB) reviewed its plan to regulate many consumer products.

FDA Petitioned to Assess Nanotech Risk

CTA and a coalition of consumer, health and environmental groups called on the FDA to address nanomaterials in consumer products.

OPI Pressured to Make Over Nail Polish Formulas

A coalition delivering letters to nail salons that sell OPI nail products is urging salons to sell safer brands of nail polish.

Ingredient Review Update from CTFA

The Cosmetic Ingredient Review (CIR) board announced updated ingredient assessments in its April 4, 2006, report.

Regulatory Review--United States and Canada: Update Online

Methods of registering cosmetic formulations are changing. This column will desribe the online registration processes for the United States and Canada.

Exclusive! Comparatively Speaking: Drugs vs. Cosmetics by Tony O'Lenick

Tony O’Lenick asks: What is the difference between a drug and cosmetic? David Steinberg explains.

CTPA Says Review Paper on AP/Deo, Breast Cancer Should Not Cause Alarm

A recent paper calling for further research into the alleged link between aluminium salts in antiperspirants and breast cancer should not constitute alarm, said the CTPA.

AAD Responds to FDA Labeling Decision on Eczema Medications
[Feb. 21, 2006]

The American Academy of Dermatology (AAD) recently issued a statement in response to the U.S. Food and Drug Administration’s (FDA) decision that a black box warning be added to labels...

FDA Commissions Study of its Drug, Biologics Application Processes

The U.S. Food and Drug Administration (FDA) released a new report that examines the way the agency reviews applications for drugs and biologics that have not previously been approved by the FDA.

Dermatology Association Urges FDA to Postpone Program for Isotretinoin Patients

Patient safety while taking isotretinoin depends on the careful oversight of the prescriber, according to the American Academy of Dermatology Association.

Regulatory Review--United States Update

California’s Safe Cosmetic Act Well, he did it. In October Governor Arnold Schwarzenegger signed into law the California Safe Cosmetic Act of 2005. As reported in my last column, this new law will not make cosmetics safer than they are now, but will increase costs for cosmetic companies and the taxpayers of the State of California while accomplishing absolutely nothing.

Can't find what you're looking for? Try searching, or looking through past issues.